Compare
Cannabis Suisse Corp. vs Advanced Oxygen Technologies Inc vs AEI Income & Growth Fund Xxii Ltd Partnership vs reAlpha Tech Corp.
| Latest fiscal year | Cannabis Suisse Corp. CSUIRevenue covers only part of its income (partial revenue) | Advanced Oxygen Technologies Inc AOXYRevenue covers only part of its income (partial revenue) | AEI Income & Growth Fund Xxii Ltd Partnership XAEIU | reAlpha Tech Corp. AIRE |
|---|---|---|---|---|
| Year ended | 2026-05-31 | 2026-06-30 | 2025-12-31 | 2025-12-31 |
| Revenue | n/a | n/a | $417.4K | $4.52M |
| Revenue growth (YoY) | n/a | n/a | -5.2% | +376.4% |
| Gross margin | n/a | n/a | n/a | 54.3% |
| Operating margin | n/a | n/a | 5.4% | -354.3% |
| Net margin | n/a | n/a | 57.9% | -389.4% |
| Net income | $122.7K | $103.0K | $241.7K | -$17.59M |
| EPS (Diluted) | $0.00 | $0.03 | n/a | -$0.23 |
| Operating cash flow | -$40.3K | $51.4K | $306.5K | -$11.26M |
| Free cash flow | n/a | n/a | n/a | -$11.31M |
| Cash & equivalents | $476 | n/a | $472.9K | $7.78M |
| Total assets | $407.5K | $657.2K | $5.18M | $21.72M |
| Total liabilities | $2.09M | $163.6K | n/a | $9.20M |
| Shareholders' equity | -$1.68M | $493.6K | n/a | $11.49M |
| Return on year-end equity | n/a | 20.9% | n/a | -153.1% |
| Shares outstanding | n/a | 3.29M | n/a | 131.74M |
Revenue, most recent five fiscal years
| Fiscal year | Cannabis Suisse Corp. | Advanced Oxygen Technologies Inc | AEI Income & Growth Fund Xxii Ltd Partnership | reAlpha Tech Corp. |
|---|---|---|---|---|
| Latest | n/a | n/a | $417.4K Ended 2025-12-31 | $4.52M Ended 2025-12-31 |
| 1 year earlier | n/a | n/a | $440.1K Ended 2024-12-31 | $948.4K Ended 2024-12-31 |
| 2 years earlier | n/a | n/a | $547.0K Ended 2023-12-31 | n/a |
| 3 years earlier | n/a | n/a | $434.4K Ended 2022-12-31 | n/a |
| 4 years earlier | n/a | n/a | $506.0K Ended 2021-12-31 | n/a |